These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26339164)
1. AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma. Kwon JH; Ahn KS; Moon YH; Park JY; Wang HJ; Choi KY; Kim G; Joh JW; Lee KG; Kang KJ J Korean Med Sci; 2015 Sep; 30(9):1253-9. PubMed ID: 26339164 [TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
3. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469 [TBL] [Abstract][Full Text] [Related]
4. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma. Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578 [TBL] [Abstract][Full Text] [Related]
6. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein. Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522 [TBL] [Abstract][Full Text] [Related]
7. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers. Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667 [TBL] [Abstract][Full Text] [Related]
9. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma. Best J; Bilgi H; Heider D; Schotten C; Manka P; Bedreli S; Gorray M; Ertle J; van Grunsven LA; Dechêne A Z Gastroenterol; 2016 Dec; 54(12):1296-1305. PubMed ID: 27936479 [No Abstract] [Full Text] [Related]
10. Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients. Burnett NP; Dunki-Jacobs EM; Callender GG; Anderson RJ; Scoggins CR; McMasters KM; Martin RC Am Surg; 2013 Jul; 79(7):716-22. PubMed ID: 23816006 [TBL] [Abstract][Full Text] [Related]
11. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery. Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401 [TBL] [Abstract][Full Text] [Related]
12. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374 [TBL] [Abstract][Full Text] [Related]
13. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma]. Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386 [TBL] [Abstract][Full Text] [Related]
15. BLZF1 expression is of prognostic significance in hepatocellular carcinoma. Huang RY; Su SG; Wu DC; Fu J; Zeng X Biochem Biophys Res Commun; 2015 Nov; 467(3):602-9. PubMed ID: 26342799 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor. Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940 [TBL] [Abstract][Full Text] [Related]
17. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753 [TBL] [Abstract][Full Text] [Related]
18. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation. Campillo A; Solanas E; Morandeira MJ; Castiella T; Lorente S; Garcia-Gil FA; Piazuelo E; de Martino A; Serrano MT Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):871-9. PubMed ID: 24922356 [TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma]. Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis. Wang D; Zhang X; Lu Y; Wang X; Zhu L Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]